VAN VAN: Open Payments
NPI 1457081770 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$846 in 28 payments from 10 companies in 2025. Trend: 2023 $1,947 · 2024 $859 · 2025 $846
Food & beverage: $736Education: $109
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $294 |
| Collegium Pharmaceutical, Inc. | 1 | $125 |
| Axsome Therapeutics, Inc. | 4 | $88 |
| Otsuka America Pharmaceutical, Inc. | 4 | $87 |
| ABBVIE INC. | 4 | $78 |
| Almatica Pharma LLC | 2 | $47 |
| Corium, LLC | 4 | $42 |
| Lundbeck LLC | 2 | $38 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| Bausch Health US, LLC | 1 | $21 |
Products named: AUSTEDO XR, REXULTI, Jornay PM, Auvelity, VRAYLAR, LOREEV XR, Azstarys, INGREZZA.
Industry payments across KS — which companies pay providers there.
